Thursday, December 2, 2021

Hiring at genpact for Associate regulatory affairs || Apply here directly


Company: Genpact

Post: Associate

Department: Regulatory Affairs


CLICK HERE TO APPLY


Responsibilities

  • Publishing and performing technical validation (eCTD/CTD/NeeS/Paper) for the LATAM and Canadian Submissions.
  • Performing final technical quality review.
  • Dispatching submission to the relevant authority ((eCTD/CTD/NeeS/Paper) or affiliate so that affiliate can dispatch to authority;
  • Performing post-submission processing activities such as receiving acknowledgment from the authority of submission receipt; capturing and the electronic receipt and metadata in RIM; communicating submission receipt to key stakeholders;
  • Capturing submissions-related correspondence from health authorities, such as uploading documentation, commitments, and metadata.

Qualifications we seek in you!

Minimum Qualifications

  • B. Pham/M.Pharm/Science Graduate
  • In-depth working knowledge of ECTD types of submission, industry-standard publishing systems.
  • Effective time management and organizational skills
  • Effectively communication
  • Flexibility to adapt to a changing environment
  • Good knowledge of ICH guidelines and CTD Structure & Expertise with Publishing Tools like Liquent, Docubridge, etc.

Preferred Qualifications

  • Experience in Pharmacy Regulatory Affairs

Genpact is an Equal Opportunity Employer and considers applicants for all positions without regard to race, color, religion or belief, sex, age, national origin, citizenship status, marital status, military/veteran status, genetic information, sexual orientation, gender identity, physical or mental disability or any other characteristic protected by applicable laws. Genpact is committed to creating a dynamic work environment that values diversity and inclusion, respect and integrity, customer focus, and innovation. For more information, visit www.genpact.com. Follow us on Twitter, Facebook, LinkedIn, and YouTube.

CLICK HERE TO APPLY


No comments:

Post a Comment